Medviso AB

Lund, Sweden  All Sweden companies → Founded 2007
Imaging AI Specialist Specialty-Focused AI
Neurosurgery Plastic Surgery Radiology
Radiology & Imaging AI Surgical AI
Grants; Formerly VC-backed (University Spin-Out, Early Stage VC, Secondary Transaction - Private) / Unfunded

Products

Segment 3DPrint
Medviso AB
Radiology & Imaging AI
Medviso AB's Segment 3DPrint is an AI-powered software for generating high-quality anatomical models from medical images for 3D printing, virtual reality, and treatment planning, supporting personalized patient care.

See all 1 product →

About Medviso AB

Medviso AB is a medical technology company specializing in advanced software solutions for medical imaging analysis and workflow optimization, with a strong emphasis on cardiovascular image analysis and 3D modeling applications. Their mission is to bridge the gap between cutting-edge research and clinical routine, empowering healthcare professionals and researchers alike. The company’s clinical software portfolio includes Segment CMR, designed for quantitative analysis of cardiac magnetic resonance images, and Segment 3DPrint, which facilitates the seamless conversion of DICOM images into high-quality, ready-to-print 3D models for diagnostic purposes, visualization, measurement, and treatment planning in various fields including orthopedic, maxillofacial, and cardiovascular applications.

Medviso actively integrates artificial intelligence into its offerings to streamline clinical workflows. For instance, they are developing AI algorithms to fully automate flow and infarct quantification in cardiac MRI exams, aiming to significantly reduce analysis time and free up resources for patient care. Beyond their clinical products, Medviso supports the research community by providing their software, Segment, freely for research purposes, which is utilized by research groups in over 75 countries worldwide for MRI, CT, and Myocardial perfusion SPECT image analysis. The company has achieved FDA 510(k) clearance and CE-marking for three of its software solutions, demonstrating their commitment to regulatory compliance and product quality.

Medviso also offers a range of medical services, including 3D modeling and 3D printed models from CT or MR images, regulatory consulting for medical software products seeking CE-marking and/or FDA 510(k) application, and custom development of advanced imaging solutions and algorithms for OEM partners. Their expertise extends to developing algorithms for analysis across various organs using MR, CT, SPECT, and PET imaging modalities.

Focus Areas

Medical imaging analysis workflow optimization cardiovascular image analysis 3D modeling cardiac magnetic resonance (CMR) cardiac computed tomography (CT) AI algorithms medical software solutions regulatory consulting 3D printing strain analysis

Business Intelligence

Key InvestorsLund University (as a collaborator and in the context of a university spin-out)
PartnershipsLund Cardiac MR Group (Lund University), Skåne University Hospital, Katholieke Universiteit Leuven, Universidade do Minho, Zhongying Medical (China), Luklan (Poland), Acton Engineering (India), Scintica (preclinical solutions), Imacor (cardiovascular core lab analysis partner), Linköping University Hospital, InfoTRON (reseller), LaserLines (reseller)
AcquisitionsNone
TechnologySoftware solutions for medical imaging analysis, AI algorithms for automatic segmentation and quantification, MATLAB for core algorithm development, DICOM reader, patient database, PACS connectivity, cloud-native (implied by web-based image transfer solutions)
FDA Clearances3 cleared products (estimated)

What Physicians Need to Know

Medical Imaging Analysis
Medviso AB specializes in comprehensive quantitative analysis of cardiac magnetic resonance (CMR) and cardiac computed tomography (CT) images. Their software, such as Segment CMR and Segment CT Research, provides tools for detailed assessment of cardiac function, volumes (LV, RV, LA, RA), flow (2D and 4D), viability, and tissue characterization (T1/T2/T2*/ECV quantification). They also offer analysis for myocardial perfusion SPECT images.
Workflow Optimization
The company focuses on streamlining clinical and research workflows through features like AI AutoMate for automation, seamless clinic-research solutions, and batch export scripts. Their user-friendly interfaces and efficient software development platform ensure quick turnaround times for updates, enhancing daily operational efficiency for healthcare professionals.
Cardiovascular Image Analysis
A core specialization is advanced cardiovascular image analysis, encompassing a broad range of tools for cardiac MRI and CT. This includes detailed analysis of all heart chambers, myocardial strain analysis (both feature tracking and tagging), and specialized modules for various cardiac pathologies and functional assessments.
3D Modeling & 3D Printing
Medviso provides solutions for 3D modeling and 3D printing, notably with Segment 3DPrint, which facilitates a seamless transition from DICOM images to high-quality, ready-to-print 3D models. They also offer a 3D Modelling Service and a Quality Management System (QMS Point-of-Care) for point-of-care 3D printed devices.
AI Algorithms
The company integrates advanced AI algorithms for automatic and semi-automatic segmentation of cardiac structures (LV, RV, LA, RA) in both MR and CT images. These deep learning methods aim to provide fast, reliable, and reproducible segmentations, significantly reducing manual effort and analysis time.
Medical Software Solutions
Medviso develops a portfolio of medical software solutions, including Segment CMR for clinical cardiac MR analysis, Segment 3DPrint for 3D modeling, and Segment CT Research for cardiac CT analysis. They also offer Segment Research (freely available for research), Segment Pre-clinical, a Strain analysis module, and custom development services.
Regulatory Consulting
With over 10 years of experience, Medviso AB offers regulatory consulting services, specializing in the framework for medical image analysis software. They assist companies in achieving CE-marking and FDA 510(k) clearance, providing comprehensive support from initial idea to regulatory application.
Strain Analysis
Medviso's Strain analysis module is a clinically approved software solution for cardiac strain analysis, recognized for having the highest reproducibility on the market. It uniquely includes both feature tracking and tagging analysis in one package, applicable to both short-axis and long-axis images.
Physician Tip

For physicians, Medviso AB's solutions offer significant advantages by providing highly reproducible and validated quantitative analysis of cardiac MR and CT images. The integration of AI algorithms in products like Segment CMR and Segment CT Research automates complex segmentation tasks, drastically reducing analysis time and allowing for a quicker diagnostic turnaround. The unique combination of feature tracking and tagging in their strain analysis module provides comprehensive insights into myocardial function. Furthermore, their FDA-cleared and CE-marked software ensures regulatory compliance and reliability for clinical decision-making. The ability to generate high-quality 3D models from imaging data can also be invaluable for surgical planning, patient education, and interventional guidance. The company's commitment to translating cutting-edge research into clinical tools means physicians benefit from state-of-the-art analysis methods developed in close collaboration with leading academic institutions.

Medviso's software solutions are designed to be compatible with DICOM images, a standard in medical imaging. Their products, such as Segment CMR and Segment CT Research, offer PACS connectivity for efficient import of images and embedded patient databases. The complete software packages can include PACS integration, report generation modules, and patient database synchronization modules. They also offer custom development for advanced imaging solutions and algorithms to OEM partners, indicating flexibility for integration into existing healthcare IT infrastructures.

Products by Medviso AB

1 product in the directory

Segment 3DPrint
Medviso AB
Radiology & Imaging AI
Medviso AB's Segment 3DPrint is an AI-powered software for generating high-quality anatomical models from medical images for 3D printing, virtual reality, and treatment planning, supporting personalized patient care.

Reviews & Opinions

No web reviews on file yet for Medviso AB. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Medviso AB.

Loading videos...

Videos load interactively. If none appear, search YouTube for Medviso AB →

View all on YouTube

Press & Coverage

Medviso
Segment version 4.3 is here, and it's our largest Segment update ever!
Medviso released Segment version 4.3, a major update that includes new AI algorithms to streamline cardiac MR analysis. This update is available for existing customers.
2026-03
Medviso
Segment CMR version 4.3 is here!
Medviso announced the release of Segment CMR version 4.3, featuring new AI algorithms, 4D flow analysis capabilities, and various workflow and reporting improvements.
2026-02
Medviso
Grant for 2025: Expansion with a Focus on Europe
Medviso received a grant for 2025 to support its international expansion, particularly focusing on the European market, to strengthen relationships and establish its presence in cardiac MRI and medical 3D printing.
2025-01
Medviso
AI for complete pre-processed CMR in clinic (AIDA Grant 2024-2025)
Medviso secured an AIDA Grant for 2024-2025 to develop AI algorithms for fully automating flow and infarct quantification in cardiac MRI exams, aiming to save significant staff time in hospitals.
2024-01
Medviso
Segment Release 4.1
Medviso released Segment 4.1, which introduces AI AutoMate for fully automated processing of DICOM data into review-ready results, and an upgrade to the Strain MITT module for four-chamber strain analysis.
2024-10
Medviso
New Segment CMR release
Medviso announced a new Segment CMR release with improvements in relaxometry analysis workflow and expanded choices and results for patient reports.
2024-02
MathWorks
Medviso Receives FDA 510(k) Approval and CE Marking for Cardiovascular Analysis Software
Medviso's MATLAB-developed image analysis software for cardiac magnetic resonance imaging has received FDA 510(k) approval in the U.S. and CE marking in Europe.
unknown
Medviso
FDA clearance of Segment 3DPrint
Medviso announced FDA 510(k) clearance for its Segment 3DPrint software package (K211966), which assists in creating 3D models from medical images.
2022-05

Frequently Asked Questions

Medviso AB offers clinical software solutions like Segment CMR for quantitative analysis of cardiac magnetic resonance (CMR) images, and Segment CT Research for cardiac computed tomography (CT) analysis. These solutions incorporate AI algorithms to streamline analysis of various cardiac functions, including LV, RV, LA, and RA.
Medviso's software, such as Segment CMR and the AI AutoMate module, is designed to optimize workflow by providing AI-powered automated segmentation and analysis of cardiac images. This streamlines the entire CMR analysis process, from sorting and loading DICOM data to performing comprehensive cardiac assessments, ultimately saving time and enhancing efficiency in clinical routine.
Medviso AB provides a comprehensive Strain Analysis Module, integrated into Segment CMR, which is the only clinically approved software on the market for cardiac strain analysis including both feature tracking and tagging analysis in one package. This module is applicable to both Cardiac MR (cine and tagging) and Cardiac CT images, allowing for global and segmental strain quantification in all four heart chambers.
Yes, Medviso AB offers Segment 3DPrint, a complete software solution that facilitates the creation of high-quality, ready-to-print 3D models directly from DICOM images. They also provide a 3D Modeling Service where experts can perform segmentation and deliver digital or printed models, which can help reduce surgical time, improve patient satisfaction through better procedure explanation, and support personalized patient care.
Medviso AB's clinical software solutions, including Segment CMR and Segment 3DPrint, are CE-marked under the Medical Device Regulation (EU) 2017/745 (MDR) and have FDA 510(k) clearance. The Strain analysis module is also included in these regulatory approvals. Medviso also offers comprehensive regulatory consulting services, from education to complete packages for CE-marking and FDA 510(k) applications.
Medviso offers customer support via email and through a dedicated 'Support Request' feature within their software, along with user manuals and tutorial videos. For pricing, they offer flexible license terms, including a 'Pay Per Case' option for clinical software like Segment CMR, which can be advantageous for sites with lower scanning volumes.
Established in 2007 and remaining family-owned, Medviso AB specializes in medical imaging analysis and workflow optimization, with a strong focus on cardiovascular applications. They actively support the research community by providing their Segment software freely for research purposes and collaborate closely with institutions like Lund Cardiac MR Group and Sku00e5ne University Hospital to develop and validate their tools.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.